Annual Total Long Term Liabilities
$58.14 M
-$17.13 M-22.76%
December 31, 2023
Summary
- As of February 7, 2025, AGIO annual total long term liabilities is $58.14 million, with the most recent change of -$17.13 million (-22.76%) on December 31, 2023.
- During the last 3 years, AGIO annual total long term liabilities has fallen by -$300.91 million (-83.81%).
- AGIO annual total long term liabilities is now -83.81% below its all-time high of $359.06 million, reached on December 31, 2020.
Performance
AGIO Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Long Term Liabilities
$45.67 M
-$4.25 M-8.50%
September 30, 2024
Summary
- As of February 7, 2025, AGIO quarterly total long term liabilities is $45.67 million, with the most recent change of -$4.25 million (-8.50%) on September 30, 2024.
- Over the past year, AGIO quarterly long term liabilities has dropped by -$4.25 million (-8.50%).
- AGIO quarterly long term liabilities is now -87.28% below its all-time high of $359.06 million, reached on December 31, 2020.
Performance
AGIO Quarterly Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Long Term Liabilities Formula
Long-Term Liabilities = Long-Term Debt + Deferred Tax Liabilities + Pension Liabilities + Other Long-Term Liabilities
AGIO Long Term Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -22.8% | -8.5% |
| 3 y3 years | -83.8% | -48.6% |
| 5 y5 years | -24.9% | -71.1% |
AGIO Long Term Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -32.3% | at low | -46.9% | at low |
| 5 y | 5-year | -83.8% | at low | -87.3% | at low |
| alltime | all time | -83.8% | +801.6% | -87.3% | +608.2% |
Agios Pharmaceuticals Long Term Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $45.67 M(-8.5%) |
| Jun 2024 | - | $49.92 M(-7.7%) |
| Mar 2024 | - | $54.10 M(-7.0%) |
| Dec 2023 | $58.14 M(-22.8%) | $58.14 M(-6.2%) |
| Sep 2023 | - | $61.99 M(-5.8%) |
| Jun 2023 | - | $65.78 M(-5.6%) |
| Mar 2023 | - | $69.66 M(-7.5%) |
| Dec 2022 | $75.28 M(-12.4%) | $75.28 M(-1.7%) |
| Sep 2022 | - | $76.55 M(-4.3%) |
| Jun 2022 | - | $80.00 M(-3.2%) |
| Mar 2022 | - | $82.61 M(-3.9%) |
| Dec 2021 | $85.94 M(-76.1%) | $85.94 M(-3.3%) |
| Sep 2021 | - | $88.84 M(-3.6%) |
| Jun 2021 | - | $92.14 M(-3.3%) |
| Mar 2021 | - | $95.30 M(-73.5%) |
| Dec 2020 | $359.06 M(+128.2%) | $359.06 M(+0.2%) |
| Sep 2020 | - | $358.23 M(+1.4%) |
| Jun 2020 | - | $353.32 M(+237.8%) |
| Mar 2020 | - | $104.58 M(-33.5%) |
| Dec 2019 | $157.33 M(+103.2%) | $157.33 M(-0.4%) |
| Sep 2019 | - | $157.89 M(-2.3%) |
| Jun 2019 | - | $161.69 M(+33.7%) |
| Mar 2019 | - | $120.97 M(+56.3%) |
| Dec 2018 | $77.42 M | $77.42 M(-8.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2018 | - | $84.12 M(-6.8%) |
| Jun 2018 | - | $90.22 M(-9.6%) |
| Mar 2018 | - | $99.83 M(-30.6%) |
| Dec 2017 | $143.95 M(-16.3%) | $143.95 M(-3.6%) |
| Sep 2017 | - | $149.28 M(-5.5%) |
| Jun 2017 | - | $157.96 M(-5.7%) |
| Mar 2017 | - | $167.51 M(-2.7%) |
| Dec 2016 | $172.07 M(+680.0%) | $172.07 M(-10.7%) |
| Sep 2016 | - | $192.59 M(-4.3%) |
| Jun 2016 | - | $201.26 M(+976.9%) |
| Mar 2016 | - | $18.69 M(-15.3%) |
| Dec 2015 | $22.06 M(+242.1%) | $22.06 M(-6.8%) |
| Sep 2015 | - | $23.67 M(-5.4%) |
| Jun 2015 | - | $25.02 M(+124.6%) |
| Mar 2015 | - | $11.14 M(+72.7%) |
| Dec 2014 | $6.45 M(-80.3%) | $6.45 M(-75.9%) |
| Sep 2014 | - | $26.77 M(-0.3%) |
| Jun 2014 | - | $26.84 M(+1.3%) |
| Mar 2014 | - | $26.49 M(-19.2%) |
| Dec 2013 | $32.79 M(-43.5%) | $32.79 M(-16.1%) |
| Sep 2013 | - | $39.10 M(-13.9%) |
| Jun 2013 | - | $45.40 M(-12.2%) |
| Mar 2013 | - | $51.70 M(-10.9%) |
| Dec 2012 | $58.00 M(-30.3%) | $58.00 M |
| Dec 2011 | $83.17 M | - |
FAQ
- What is Agios Pharmaceuticals annual total long term liabilities?
- What is the all time high annual total long term liabilities for Agios Pharmaceuticals?
- What is Agios Pharmaceuticals annual total long term liabilities year-on-year change?
- What is Agios Pharmaceuticals quarterly total long term liabilities?
- What is the all time high quarterly long term liabilities for Agios Pharmaceuticals?
- What is Agios Pharmaceuticals quarterly long term liabilities year-on-year change?
What is Agios Pharmaceuticals annual total long term liabilities?
The current annual total long term liabilities of AGIO is $58.14 M
What is the all time high annual total long term liabilities for Agios Pharmaceuticals?
Agios Pharmaceuticals all-time high annual total long term liabilities is $359.06 M
What is Agios Pharmaceuticals annual total long term liabilities year-on-year change?
Over the past year, AGIO annual total long term liabilities has changed by -$17.13 M (-22.76%)
What is Agios Pharmaceuticals quarterly total long term liabilities?
The current quarterly long term liabilities of AGIO is $45.67 M
What is the all time high quarterly long term liabilities for Agios Pharmaceuticals?
Agios Pharmaceuticals all-time high quarterly total long term liabilities is $359.06 M
What is Agios Pharmaceuticals quarterly long term liabilities year-on-year change?
Over the past year, AGIO quarterly total long term liabilities has changed by -$4.25 M (-8.50%)